Targeting claudin-4 in human pancreatic cancer

Bibliography

• Michl P, Barth C, Buchholz M, Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res 2003;63(19):6265-71
   Google Scholar
• Morin PJ. Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 2005;65(21):9603-6
   PubMed Web of Science ®Google Scholar
• Karanjawala ZE, Illei PB, Ashfaq R, New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8. Am J Surg Pathol 2008;32(2):188-96
   PubMed Web of Science ®Google Scholar
• Gumbiner BM. Breaking through the tight junction barrier. J Cell Biol 1993;123(6 Pt 2):1631-3
   PubMed Web of Science ®Google Scholar
• Schneeberger EE, Lynch RD. Structure, function, and regulation of cellular tight junctions. Am J Physiol 1992;262(6 Pt 1):L647-61
   Google Scholar
• van Meer G, Simons K. The function of tight junctions in maintaining differences in lipid composition between the apical and the basolateral cell surface domains of MDCK cells. EMBO J 1986;5(7):1455-64
   PubMed Web of Science ®Google Scholar
• Cereijido M, Valdes J, Shoshani L, Role of tight junctions in establishing and maintaining cell polarity. Annu Rev Physiol 1998;60:161-77
   PubMed Web of Science ®Google Scholar
• Matter K, Balda MS. Signalling to and from tight junctions. Nat Rev Mol Cell Biol 2003;4(3):225-36
   PubMed Web of Science ®Google Scholar
• Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 2004;286(6):C1213-28
   PubMed Web of Science ®Google Scholar
• Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001;2(4):285-93
   PubMed Web of Science ®Google Scholar
• Sawada N, Murata M, Kikuchi K, Tight junctions and human diseases. Med Electron Microsc 2003;36(3):147-56
   PubMedGoogle Scholar
• Ikenouchi J, Furuse M, Furuse K, Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol 2005;171(6):939-45
   PubMed Web of Science ®Google Scholar
• Gonzalez-Mariscal L, Tapia R, Chamorro D. Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 2008;1778(3):729-56
   PubMed Web of Science ®Google Scholar
• Kojima T, Murata M, Yamamoto T, Tight junction proteins and signal transduction pathways in hepatocytes. Histol Histopathol 2009;24(11):1463-72
   Google Scholar
• Meredith LW, Wilson GK, Fletcher NF, Hepatitis C virus entry: beyond receptors. Rev Med Virol 2012;22(3):182-93
   PubMed Web of Science ®Google Scholar
• Krug SM, Gunzel D, Conrad MP, Charge-selective claudin channels. Ann NY Acad Sci 2012;1257(1):20-8
   Google Scholar
• Fujita K, Katahira J, Horiguchi Y, Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett 2000;476(3):258-61
   PubMed Web of Science ®Google Scholar
• McClane BA, Chakrabarti G. New insights into the cytotoxic mechanisms of clostridium perfringens enterotoxin. Anaerobe 2004;10(2):107-14
   PubMed Web of Science ®Google Scholar
• Michl P, Buchholz M, Rolke M, Claudin-4: a new target for pancreatic cancer treatment using clostridium perfringens enterotoxin. Gastroenterology 2001;121(3):678-84
   PubMed Web of Science ®Google Scholar
• Sahin U, Koslowski M, Dhaene K, Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development. Clin Cancer Res 2008;14(23):7624-34
   PubMed Web of Science ®Google Scholar
• Suzuki M, Kato-Nakano M, Kawamoto S, Therapeutic antitumor efficacy of monoclonal antibody against Claudin-4 for pancreatic and ovarian cancers. Cancer Sci 2009;100(9):1623-30
   PubMed Web of Science ®Google Scholar
• Katahira J, Sugiyama H, Inoue N, Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo. J Biol Chem 1997;272(42):26652-8
   PubMed Web of Science ®Google Scholar
• Saeki R, Kondoh M, Kakutani H, A novel tumor-targeted therapy using a claudin-4-targeting molecule. Mol Pharmacol 2009;76(4):918-26
   PubMed Web of Science ®Google Scholar
• Neesse A, Griesmann H, Gress TM, Claudin-4 as therapeutic target in cancer. Arch Biochem Biophys 2012; PubMed: 22286027
   Google Scholar
• Sato N, Fukushima N, Maitra A, Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. Am J Pathol 2004;164(3):903-14
   Google Scholar
• Lee JH, Kim KS, Kim TJ, Immunohistochemical analysis of claudin expression in pancreatic cystic tumors. Oncol Rep 2011;25(4):971-8
   Google Scholar
• Tsutsumi K, Sato N, Tanabe R, Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma. Ann Surg Oncol 2011; PubMed: 21837532
   Google Scholar
• Tanaka M, Shibahara J, Fukushima N, Claudin-18 is an early-stage marker of pancreatic carcinogenesis. J Histochem Cytochem 2011;59(10):942-52
   PubMed Web of Science ®Google Scholar
• Ito T, Kojima T, Yamaguchi H, Transcriptional regulation of claudin-18 via specific protein kinase C signaling pathways and modification of DNA methylation in human pancreatic cancer cells. J Cell Biochem 2011;112(7):1761-72
   PubMed Web of Science ®Google Scholar
• Soini Y, Takasawa A, Eskelinen M, Expression of claudins 7 and 18 in pancreatic ductal adenocarcinoma: association with features of differentiation. J Clin Pathol 2012;65(5):431-6
   Google Scholar
• Bodnar AG, Ouellette M, Frolkis M, Extension of life-span by introduction of telomerase into normal human cells. Science 1998;279(5349):349-52
   PubMed Web of Science ®Google Scholar
• Vaziri H, Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 1998;8(5):279-82
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Kojima T, Ito T, Transcriptional control of tight junction proteins via a protein kinase C signal pathway in human telomerase reverse transcriptase-transfected human pancreatic duct epithelial cells. Am J Pathol 2010;177(2):698-712
   PubMed Web of Science ®Google Scholar
• Kojima T, Takasawa A, Kyuno D, Downregulation of tight junction-associated MARVEL protein marvelD3 during epithelial-mesenchymal transition in human pancreatic cancer cells. Exp Cell Res 2011;317(16):2288-98
   Google Scholar
• Balda MS, Gonzalez-Mariscal L, Matter K, Assembly of the tight junction: the role of diacylglycerol. J Cell Biol 1993;123(2):293-302
   PubMed Web of Science ®Google Scholar
• Andreeva AY, Piontek J, Blasig IE, Assembly of tight junction is regulated by the antagonism of conventional and novel protein kinase C isoforms. Int J Biochem Cell Biol 2006;38(2):222-33
   Google Scholar
• Ellis B, Schneeberger EE, Rabito CA. Cellular variability in the development of tight junctions after activation of protein kinase C. Am J Physiol 1992;263(2 Pt 2):F293-300
   Google Scholar
• Sjo A, Magnusson KE, Peterson KH. Distinct effects of protein kinase C on the barrier function at different developmental stages. Biosci Rep 2003;23(2-3):87-102
   Google Scholar
• Kyuno D, Kojima T, Ito T, Protein kinase Calpha inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens enterotoxin via claudin-4. Cell Tissue Res 2011;346(3):369-81
   Google Scholar
• Kumei S, Motomura W, Yoshizaki T, Troglitazone increases expression of E-cadherin and claudin 4 in human pancreatic cancer cells. Biochem Biophys Res Commun 2009;380(3):614-19
   Google Scholar
• Yamaguchi H, Kojima T, Ito T, Effects of clostridium perfringens enterotoxin via claudin-4 on normal human pancreatic duct epithelial cells and cancer cells. Cell Mol Biol Lett 2011;16(3):385-97
   Google Scholar
• Deer EL, Gonzalez-Hernandez J, Coursen JD, Phenotype and genotype of pancreatic cancer cell lines. Pancreas 2010;39(4):425-35
   PubMed Web of Science ®Google Scholar
• Tsukita S, Yamazaki Y, Katsuno T, Tight junction-based epithelial microenvironment and cell proliferation. Oncogene 2008;27(55):6930-8
   PubMed Web of Science ®Google Scholar
• Rangel LB, Agarwal R, D'Souza T, Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res 2003;9(7):2567-75
   Google Scholar
• Boylan KL, Misemer B, Derycke MS, Claudin 4 is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation. Int J Mol Sci 2011;12(2):1334-58
   Google Scholar
• Ogawa M, Kojima T, Someya M, Epidermal growth factor modulates claudins and tight junctional functions in ovarian cancer cell lines. Histochem Cell Biol 2012; PubMed: 22544349
   Google Scholar
• Ahmed N, Maines-Bandiera S, Quinn MA, Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium. Am J Physiol Cell Physiol 2006;290(6):C1532-42
   Google Scholar
• Long H, Crean CD, Lee WH, Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res 2001;61(21):7878-81
   Google Scholar
• Maeda T, Murata M, Chiba H, Claudin-4-targeted therapy using clostridium perfringens enterotoxin for prostate cancer. Prostate 2012;72(4):351-60
   Google Scholar
• Sonoda N, Furuse M, Sasaki H, Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier. J Cell Biol 1999;147(1):195-204
   PubMed Web of Science ®Google Scholar
• Gao Z, Xu X, McClane B, C terminus of clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to taxol and carboplatin. Clin Cancer Res 2011;17(5):1065-74
   Google Scholar
• Cocco E, Casagrande F, Bellone S, Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer. BMC Cancer 2010;10:349
   PubMedGoogle Scholar
• Yong KT. Anti-claudin-4-conjugated highly luminescent nanoparticles as biological labels for pancreatic cancer sensing. Methods Mol Biol 2011;762:427-38
   Google Scholar
• Saeki R, Kondoh M, Kakutani H, A claudin-targeting molecule as an inhibitor of tumor metastasis. J Pharmacol Exp Ther 2010;334(2):576-82
   Google Scholar
• Kakutani H, Kondoh M, Saeki R, Claudin-4-targeting of diphtheria toxin fragment A using a C-terminal fragment of Clostridium perfringens enterotoxin. Eur J Pharm Biopharm 2010;75(2):213-17
   Google Scholar
• Takahashi A, Saito Y, Kondoh M, Creation and biochemical analysis of a broad-specific claudin binder. Biomaterials 2012;33(12):3464-74
   PubMed Web of Science ®Google Scholar